From Lab Bench to Clinic: U.S. Early Development AND HPAPI Manufacturing In Malvern, PA

Located in Malvern, Pennsylvania, this U.S. facility is purpose‑built to support early‑stage and clinical development for small‑molecule programs requiring speed, flexibility, and high containment. The site combines process development, analytical development, and cGMP manufacturing under one roof, enabling efficient progression from grams to tens of kilograms for clinical supply. Specialized infrastructure supports highly potent APIs and controlled substances, with multiple isolator‑based kilo labs designed to manage low OEL compounds while maintaining operator safety and product integrity.

A cGMP pilot plant, ISO‑8 cleanroom, and robust analytical and QC capabilities — including on‑site NMR and advanced LC‑MS platforms — allow teams to troubleshoot, optimize, and scale processes without unnecessary handoffs. Process safety tools, solid‑state expertise, and small‑scale commercial manufacturing further strengthen development continuity. Proximity to major U.S. biotech and pharma hubs in the Northeast adds logistical and collaboration advantages for programs requiring close oversight.

Together, these capabilities create a reliable environment for advancing complex intermediates and APIs into the clinic under cGMP conditions.